EVERSANA and S3 Connected Health Announce Strategic Partnership
EVERSANA, the pioneer of next generation commercial services to the global life sciences industry and S3 Connected Health, an award-winning partner in digital health solutions for pharma, announced a strategic partnership to offer end-to-end digital health and commercialization services for pharmaceutical companies.
Recommended AI News: Verimatrix Joins AWS for Media & Entertainment Initiative
S3 Connected Health’s proven experience in design, creation and operation of digital health solutions will complement EVERSANA’s end-to-end commercialization services (including patient support and adherence models), enabling life sciences companies to:
- Impact brand planning and optimize performance with digital health solutions, to provide personalized support based on real-world insights.
- Improve outcomes through next generation patient services, and meet the demands of value-based care using digital health solutions and human-based support to deliver integrated therapy and condition management services.
Recommended AI News: Narrative Reaches New Milestone; Achieves 1.5 Trillion Data Transactions
“As we’ve rapidly expanded our services across Europe, we started working with S3 Connected Health and immediately saw the opportunity to blend digital health solutions throughout our commercial support of the product and patient journeys,” said Mike Ryan, Executive Vice President, Europe, EVERSANA. “Now more than ever, we can work together to impact brand performance, improve patient experiences, or even deliver and launch life-changing DTX products in market.”
Jim O’Donoghue, President of S3 Connected Health said, “Digital health solutions are now vital for delivering better, more sustainable healthcare for patients and clinicians into the future. Through this collaboration with EVERSANA we will be able to offer complete end-to-end solutions and services for digital health from co-creation through to commercialization, providing a unique service to our combined customer base.”